Christopher Barbieri, M.D., Ph.D., Assistant Professor in Urology and in Cell & Developmental Biology at Weill Cornell Medicine, was interviewed by the Prostate Cancer Foundation on active surveillance for prostate cancer patients. He addresses many of the common questions that patients and providers ask regarding eligibility for active surveillance and treatment protocol.
"There's no one way to select candidates for active surveillance," says urologist and molecular biologist Chris Barbieri, M.D., Ph.D., who treats men with all kinds of prostate cancer and works with several hundred patients currently on active surveillance.
Read the full interview via Prostate Cancer Foundation here: https://www.pcf.org/c/interview-with-an-expert-active-surveillance/?utm_...
To learn more about Dr. Barbieri, please visit his physician profile page.
To learn more about prostate cancer, please visit our prostate cancer webpages.
